These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9788526)

  • 1. Laboratory validation study of drug evaluation and classification program: alprazolam, d-amphetamine, codeine, and marijuana.
    Heishman SJ; Singleton EG; Crouch DJ
    J Anal Toxicol; 1998 Oct; 22(6):503-14. PubMed ID: 9788526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory validation study of drug evaluation and classification program: ethanol, cocaine, and marijuana.
    Heishman SJ; Singleton EG; Crouch DJ
    J Anal Toxicol; 1996 Oct; 20(6):468-83. PubMed ID: 8889684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling drug detection and diagnosis with the 'drug evaluation and classification program'.
    Schechtman E; Shinar D
    Accid Anal Prev; 2005 Sep; 37(5):852-61. PubMed ID: 15935319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of alprazolam in blood from impaired drivers and forensic autopsies were not much different but showed a high prevalence of co-ingested illicit drugs.
    Jones AW; Holmgren A
    J Psychopharmacol; 2013 Mar; 27(3):276-81. PubMed ID: 23257168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
    Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
    Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of pupil size standards used by police officers for detecting drug impairment.
    Richman JE; McAndrew KG; Decker D; Mullaney SC
    Optometry; 2004 Mar; 75(3):175-82. PubMed ID: 15058699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
    Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
    Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug identification performance on the basis of observable signs and symptoms.
    Shinar D; Schechtman E
    Accid Anal Prev; 2005 Sep; 37(5):843-51. PubMed ID: 15885613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High concentrations of diazepam and nordiazepam in blood of impaired drivers: association with age, gender and spectrum of other drugs present.
    Jones AW; Holmgren A; Holmgren P
    Forensic Sci Int; 2004 Nov; 146(1):1-7. PubMed ID: 15485715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of the initial medical examination on matters relating to persons suspected of driving under the influence of amphetamine and its analogs or delta9-tetrahydrocannabinol based on the materials the Department of Forensic Medicine, Pomeranian Medical University in Szczecin].
    Wolski S; Lewandowska E; Kurzejamska-Parafiniuk M
    Ann Acad Med Stetin; 2013; 59(2):147-56. PubMed ID: 25026768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
    Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
    Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis.
    Raikos N; Schmid H; Nussbaumer S; Ambach L; Lanz S; Längin A; König S; Roth N; Auwärter V; Weinmann W
    Forensic Sci Int; 2014 Oct; 243():130-6. PubMed ID: 25173986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of 12 commonly found compounds in DUID cases in whole blood using fully automated supported liquid extraction and UHPLC-MS/MS.
    Kristoffersen L; Langødegård M; Gaare KI; Amundsen I; Terland MN; Strand DH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Sep; 1093-1094():8-23. PubMed ID: 29980102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blind trials of an onsite saliva drug test for marijuana and opiates.
    Jehanli A; Brannan S; Moore L; Spiehler VR
    J Forensic Sci; 2001 Sep; 46(5):1214-20. PubMed ID: 11569567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
    Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
    Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between self-report of cannabis use and toxicological detection of THC/THCCOOH in blood and THC in oral fluid in drivers in a roadside survey.
    Van der Linden T; Silverans P; Verstraete AG
    Drug Test Anal; 2014; 6(1-2):137-42. PubMed ID: 23939912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting categories of drugs used by suspected drug-impaired drivers using the Drug Evaluation and Classification Program tests.
    Porath AJ; Beirness DJ
    Traffic Inj Prev; 2019; 20(3):255-263. PubMed ID: 30946603
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
    Huestis MA; Henningfield JE; Cone EJ
    J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.